OncoResponse
OncoResponse is a company providing cancer research into immunotherapies and the newest technologies for oncologists.
4
Funding Rounds
$129.5m
Money raised
Funding
Funding series
Funding Series Analysis
The company OncoResponse has raised a total of $29.5m in funding over 4 rounds.
Key Insights:
- OncoResponse Series A round, March 2017: $22.5m
- OncoResponse Series A round, October 2016: $7m
- OncoResponse Inc funding round, March 2021: $60m
- OncoResponse funding round, September 2018: $40m
OncoResponse Series A round, March 2017
$22.5m
OncoResponse Series A round, October 2016
$7m
OncoResponse Inc funding round, March 2021
$60m
OncoResponse funding round, September 2018
$40m
Industries
OncoResponse is active in the following industries: